StockData
Contineum Therapeutics, Inc. logo

Contineum Therapeutics, Inc. (CTNM) stock

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.24−0.31 (-3.25%)

Close on Nov 18, 2026Market cap $347.62MP/E –Yield –

Contineum Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Contineum Therapeutics's pe ratio was 2.5× on Jul 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jul 31, 20242.5×–

More Contineum Therapeutics figures

See a number that looks wrong?